ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 140 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,956 | +42.2% | 1,294 | +100.0% | 0.00% | – |
Q2 2023 | $18,249 | -32.4% | 647 | -32.7% | 0.00% | – |
Q2 2022 | $27,000 | -47.1% | 962 | -13.5% | 0.00% | – |
Q1 2022 | $51,000 | -50.0% | 1,112 | -8.7% | 0.00% | – |
Q4 2021 | $102,000 | +1357.1% | 1,218 | +1082.5% | 0.00% | – |
Q3 2021 | $7,000 | – | 103 | +1371.4% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 7 | -99.5% | 0.00% | – |
Q3 2020 | $43,000 | -10.4% | 1,305 | +30.5% | 0.00% | – |
Q2 2020 | $48,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |